Cours suspendu

Communiqués WPD Pharmaceuticals Inc.

Actions

WBIO

CA92941F2044

Sociétés holdings

Marché Fermé - Canadian Securities Exchange 20:09:41 20/02/2025			Varia. 5j.	Varia. 1 janv.
0,0700 ^CAD	-.--%		-.--%	-

17/04/25	Mabion signe un contrat d'environ 2 millions de zlotys avec WPD Pharmaceuticals	RE
12/12/24	WPD Pharmaceuticals Inc. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2024	CI

Communiqués

08/05/25	Canadian Investment Regulatory Organization Trading Halt - WBIO	AQ
20/12/24	CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO)	NE
20/12/24	Canadian Investment Regulatory Organization Trade Resumption - WBIO	AQ
06/12/24	Canadian Investment Regulatory Organization Trading Halt - WBIO	AQ
05/12/24	WPD Pharmaceuticals : PROPOSED SHARE CONSOLIDATION OF WPD’S COMMON SHARES	PU
25/07/24	WPD Pharmaceuticals : ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES	PU
07/06/24	WPD Pharmaceuticals : ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES	PU
30/05/24	WPD Pharmaceuticals : REINSTATEMENT OF TRADING OF WPD'S COMMON SHARES AND ANNUAL GENERAL MEETING	PU
24/05/24	CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO)	NE
24/05/24	Canadian Investment Regulatory Organization Trade Resumption - WBIO	AQ
16/05/24	WPD Pharmaceuticals : Receives Full Revocation of Cease Trade Order	PU
10/05/24	WPD Pharmaceuticals : Announces Filing of Annual Financial Statements and Provides Corporate Update	PU
02/11/23	WPD Pharmaceuticals : Sp. z o. o., received the second tranche of the funds	PU
08/09/23	WPD Pharmaceuticals : Sp. z o. o., received the first tranche of the funds	PU
01/09/23	WPD Pharmaceuticals : Polish Subsidiary Signs Investment Agreement with ACRX Investments Limited	PU
16/06/23	WPD Pharmaceuticals : Announces Closing of Convertible Debenture Private Placement	PU
18/11/22	WPD Pharmaceuticals : Provides a Corporate Update	PU
11/07/22	IIROC Trading Halt - WBIO	AQ
16/05/22	WPD Pharmaceuticals Signs Annex to License Agreement with Wake Forest University Health Sciences	AQ
16/05/22	WPD Pharmaceuticals Signs Annex to License Agreement with Wake Forest University Health Sciences	GL
07/03/22	WPD Pharmaceuticals Signs Consortium Agreement on EuroNanoMed Project	GL
09/02/22	WPD Pharmaceuticals Announces Proposed Restructuring of Polish Subsidiary	GL
03/02/22	WPD Pharmaceuticals Announces Appointment of New Director	AQ
25/01/22	WPD Pharmaceuticals Enters into Amended and Restated Sublicense Agreement with Moleculin Biotech	GL
25/01/22	WPD Pharmaceuticals Enters into Amended and Restated Sublicense Agreement with Moleculin Biotech	GL